278 related articles for article (PubMed ID: 25446102)
1. Inhibition of MEK/ERK activation attenuates autophagy and potentiates pemetrexed-induced activity against HepG2 hepatocellular carcinoma cells.
Tong Y; Huang H; Pan H
Biochem Biophys Res Commun; 2015 Jan; 456(1):86-91. PubMed ID: 25446102
[TBL] [Abstract][Full Text] [Related]
2. Autophagy inhibition sensitizes KU-0063794-mediated anti-HepG2 hepatocellular carcinoma cell activity in vitro and in vivo.
Yongxi T; Haijun H; Jiaping Z; Guoliang S; Hongying P
Biochem Biophys Res Commun; 2015 Sep; 465(3):494-500. PubMed ID: 26278819
[TBL] [Abstract][Full Text] [Related]
3. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
[TBL] [Abstract][Full Text] [Related]
4. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling.
Zou M; Lu N; Hu C; Liu W; Sun Y; Wang X; You Q; Gu C; Xi T; Guo Q
Cell Signal; 2012 Aug; 24(8):1722-32. PubMed ID: 22560876
[TBL] [Abstract][Full Text] [Related]
5. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
Ou DL; Shen YC; Liang JD; Liou JY; Yu SL; Fan HH; Wang DS; Lu YS; Hsu C; Cheng AL
Clin Cancer Res; 2009 Sep; 15(18):5820-8. PubMed ID: 19737956
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
7. Platycodin D triggers autophagy through activation of extracellular signal-regulated kinase in hepatocellular carcinoma HepG2 cells.
Li T; Tang ZH; Xu WS; Wu GS; Wang YF; Chang LL; Zhu H; Chen XP; Wang YT; Chen Y; Lu JJ
Eur J Pharmacol; 2015 Feb; 749():81-8. PubMed ID: 25592318
[TBL] [Abstract][Full Text] [Related]
8. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
9. Autophagy prevention sensitizes AKTi-1/2-induced anti-hepatocellular carcinoma cell activity in vitro and in vivo.
Zhang Q; Yang M; Qu Z; Zhou J; Jiang Q
Biochem Biophys Res Commun; 2016 Nov; 480(3):334-340. PubMed ID: 27756618
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C
Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882
[TBL] [Abstract][Full Text] [Related]
11. Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells.
Wang Y; Han C; Lu L; Magliato S; Wu T
Hepatology; 2013 Sep; 58(3):995-1010. PubMed ID: 23504944
[TBL] [Abstract][Full Text] [Related]
12. The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma [corrected] cells.
Cheng P; Ni Z; Dai X; Wang B; Ding W; Rae Smith A; Xu L; Wu D; He F; Lian J
Cell Death Dis; 2013 Feb; 4(2):e489. PubMed ID: 23392177
[TBL] [Abstract][Full Text] [Related]
13. Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells.
Cheng SB; Wu LC; Hsieh YC; Wu CH; Chan YJ; Chang LH; Chang CM; Hsu SL; Teng CL; Wu CC
J Agric Food Chem; 2012 Sep; 60(38):9620-30. PubMed ID: 22946656
[TBL] [Abstract][Full Text] [Related]
14. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
Manov I; Pollak Y; Broneshter R; Iancu TC
FEBS J; 2011 Sep; 278(18):3494-507. PubMed ID: 21790999
[TBL] [Abstract][Full Text] [Related]
16. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.
Zhang J; Lan SJ; Liu QR; Liu JM; Chen XQ
Mol Pharmacol; 2013 May; 83(5):1109-19. PubMed ID: 23478801
[TBL] [Abstract][Full Text] [Related]
17. Autophagy inhibition enhances etoposide-induced cell death in human hepatoma G2 cells.
Xie BS; Zhao HC; Yao SK; Zhuo DX; Jin B; Lv DC; Wu CL; Ma DL; Gao C; Shu XM; Ai ZL
Int J Mol Med; 2011 Apr; 27(4):599-606. PubMed ID: 21274505
[TBL] [Abstract][Full Text] [Related]
18. Glycyrrhetinic Acid triggers a protective autophagy by activation of extracellular regulated protein kinases in hepatocellular carcinoma cells.
Tang ZH; Li T; Chang LL; Zhu H; Tong YG; Chen XP; Wang YT; Lu JJ
J Agric Food Chem; 2014 Dec; 62(49):11910-6. PubMed ID: 25403108
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer.
Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Chang YG; Kim MG; Park WS; Lee JY; Lee SY; Chu IS; Nam SW
Hepatology; 2012 Aug; 56(2):644-57. PubMed ID: 22392728
[TBL] [Abstract][Full Text] [Related]
20. Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma.
Wiesenauer CA; Yip-Schneider MT; Wang Y; Schmidt CM
J Am Coll Surg; 2004 Mar; 198(3):410-21. PubMed ID: 14992744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
